The SA Journal Diabetes & Vascular Disease Vol 8 No 3 (September 2011) - page 26

A leading partner
in the field of diabetic research
www.servier.com
GLICLAZIDE MODIFIED RELEASE
For full prescribing information, refer to package insert approved by the medical regulatory authority. DIAMICRON® MR 30mg Tablets. Gliclazide 30mg. Reg. No. 35/21.2/0178. Each DIAMICRON
Modified Release 30mg tablet contains 30mg Gliclazide. PHARMACOLOGICAL CLASSIFICATION A21.2 Oral Hypoglycaemics. DIAGLUCIDE® MR 30mg Tablets. Gliclazide 30mg. Reg. No. 38/21.2/0223.
Each DIAGLUCIDE ® Modified Release 30mg tablet contains 30mg Gliclazide. Reg. No.38/21.2/0223. PHARMACOLOGICAL CLASSIFICATION A21.2 Oral Hypoglycaemics. PRODUCT REGISTRATION
NUMBER 35/21.2/0178. NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE: SERVIER LABORATORIES SOUTH AFRICA (Pty) Ltd. Reg. No. 72/14307/07. Building Number 4,
Country Club Estate, 21 Woodlands Drive, Woodmead 2191. PO Box 930, Rivonia 2128, Republic of South Africa. Tel: +27(0) 861 700 900. Fax: +27(0)11 525 3401. BIOGARAN SA (Pty) Ltd. Reg. No.
2001/011749/07. Building Number 4, Country Club Estate, 21 Woodlands Drive, Woodmead 2191. PO Box 930, Rivonia 2128, Republic of South Africa. Tel: +27(0)11 525 3448. Fax: +27(0) 866 465 144.
1011/2/DMR/A/1